Investing in a Healthy Future We create and develop high impact life science companies based on technologies exclusively licensed from top research institutions worldwide. Subscribe to the VIC newsletter Register for a VIC Investor Network Webinar OUR Approach We Bring World ChangingTechnologies to Global Markets VIC’s novel business model manages risks, provideshigher upsides, and lowers […]
Investment Type: Venture Capital
Portfolio 16
| Date | Name | Website | Total Raised | Location |
| - | BlueInGree... | blueingreen.com | - | United Sta... |
| - | Vixiar Med... | vixiar.com | $3M | - |
| - | neurexisth... | neurexistherapeutics.com | $3M | United Sta... |
| - | Zebra Anal... | zebraanalytix.com | $60K | United Sta... |
| - | SFC Fluidi... | sfc-fluidics.com | - | United Sta... |
| - | filtravate... | filtravate.com | - | United Sta... |
| - | BiologicsM... | biologicsmd.com | - | United Sta... |
| - | Akeso Biom... | akesobiomedical.com | $4.4M | - |
| - | celliasci.... | celliasci.com | - | - |
| - | Tesseract ... | tesseractinnovations.com | - | United Sta... |
Show more
Mentions in press and media 18
| Date | Title | Description |
| 15.10.2024 | VIC Tech Announces Formation of i-Seq Biotechnology to Pioneer Broad-Spectrum Vaccines and Therapeutics | i-Seq Biotechnology Aiming to address global infectious disease challenges with next-generation solutions FAYETTEVILLE, Ark., Oct. 15, 2024 /PRNewswire-PRWeb/ -- VIC Tech, a leading builder of high-impact, innovative life science companies,... |
| 06.08.2024 | Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies | Nob Hill Therapeutics dry powder nebulizer (DryNeb) Funding Led by Tramway Venture Partners Includes Key Appointments to the Board and Accelerates the Development of High-Dose Lung Delivery Solutions. ALBUQUERQUE, N.M., Aug. 6, 2024 /PRNews... |
| 20.10.2022 | CardioWise, Inc. Named a Finalist in the Rising Star Clinical Diagnostics Tool or Platform Category by UCSF Health Hub | UCSF Health Hub Digital Awards “The goal of the UCSF Digital Health Awards is to ultimately help patients access amazing innovations by recognizing and awarding the great companies with the best in-market digital products and services."... |
| 23.08.2022 | Nob Hill Therapeutics Awarded HHS Phase II Grant and Announces New CEO | “I’m thrilled to join Nob Hill. Nob Hill is poised to deliver both meaningful therapies to patients and value to its investors. The Nob Hill team has done tremendous work to date, and I look forward to working with them." added, Noel G... |
| 16.08.2022 | CardioWise, Inc. Selected for the Inaugural Edison Accelerator By GE Healthcare in Collaboration with Nex Cubed | "CardioWise SQuEEZ analysis can provide caregivers with an easy-to-read, quantitative 4D color model that allows physicians to make better, more informed decisions about their patient’s care," said Jack Coats, CEO of CardioWise FA... |
| 20.04.2022 | Cellia Science Formed to Develop and Commercialization Point-of-Care Hematology Analyzers | “Because our technology appears to achieve fast, reliable, quantitative, and simple blood cell analysis in a low-cost configuration,” said Dr. Robles, CSO “it has great potential to simplify and improve clinical hematological analysis.” FAY... |
| 22.11.2021 | Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth | Dr. Pritchard commented “I am delighted to be working with such distinguished experts in a field of unmet medical need. I think the whole Board are excited by the potential of the DryNeb approach.” ALBUQUERQUE, N.M. (PRWEB) November 22, 202... |
| 10.11.2021 | VIC Technology Venture Development Adds Laura Lyons to Board of Directors | "I look forward to collaborating with the innovative minds at VIC to bring new technology to the market that prioritizes the quality and safety of patient care,” says Lyons. FAYETTEVILLE, Ark. (PRWEB) November 10, 2021 VIC Technology V... |
| 25.10.2021 | Akeso Biomedical Receives EU Authorization for CI-FER® as a Feed Additive in Piglets | "We are very excited to bring CI-FER® to the European market ahead of the EU ban on medicinal use of zinc oxide, widely used at high veterinary doses to improve gut health, reduce diarrhea, and enhance performance.” said Simon Williams... |
| 14.10.2021 | Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic | “We are encouraged by the support provided by NIH to move this promising, transformative product towards the clinic,” said Dr. Michael Artinger, CEO of Neurexis Therapeutics AURORA, Colo. (PRWEB) October 14, 2021 Neurexis Therapeutics, Inco... |
Show more